The Supreme Court on May 4 reinstated mail-order access to the widely used abortion drug mifepristone, a temporary decision that gives the justices more time to consider the issue.
The court intervened after the Food and Drug Administration was ordered on May 1 to revive a requirement that doctors prescribe the drug only after an in-person exam. It was the first time access to mifepristone had been significantly curtailed during years of litigation over the drug, which was first approved in 2000.
At the request of drugmakers, Justice Samuel Alito paused until May 11 the restrictive ruling by a lower court while the full court decides what the rules for mifepristone should be as Louisiana challenges expanded access.
“This ruling is not final − keep watching,” Nancy Northup, head of the Center for Reproductive Rights, said in a statement. “Getting abortion pills through telehealth has been a lifeline for women since Roe v. Wade was overturned. There is no reason people shouldn’t be able to get mifepristone at a pharmacy or through the mail.”
At the MAHA Institute's "Mental Health & Overmedicalization Summit" in the nation's capital, the Health and...
Three people have died in an outbreak of a dangerous respiratory virus on a cruise ship...
